Perilipin-related protein regulates lipid metabolism in C. elegans
A peer-reviewed article of this Preprint also exists.
Author and article information
Abstract
The perilipins are lipid droplet surface proteins that contribute to fat metabolism by controlling the access of lipids to lipolytic enzymes. Perilipins have been identified in organisms as diverse as metazoa, fungi, and amoebas but strikingly not in nematodes. Here we identify the protein encoded by the W01A8.1 gene in Caenorhabditis elegans as the closest homologue of metazoan perilipin. We demonstrate that nematode W01A8.1 is a cytoplasmic protein residing on lipid droplets. Human perilipins 1 and 2 localize in transgenic C. elegans on the same structures as proteins expressed from W01A8.1 gene. Inhibition and elimination of W01A8.1 affects the appearance of lipid droplets especially visible as the formation of large lipid droplets localized around the dividing nucleus during the early zygotic divisions. This phenomenon disappears in later stages of embryogenesis indicating the existence of an additional mechanism of lipid regulation in C. elegans. Our results demonstrate that perilipin-related regulation of fat metabolism is conserved in nematodes and provide new possibilities for functional studies of lipid metabolism.
Cite this as
2015. Perilipin-related protein regulates lipid metabolism in C. elegans. PeerJ PrePrints 3:e904v2 https://doi.org/10.7287/peerj.preprints.904v2Author comment
This is version 2 of a submission to PeerJ. An old version of Figure 1 is mistakenly submitted in version 1 and is corrected in version 2.
Sections
Supplemental Information
Scheme of W01A8.1 gene, expressed isoforms and preparation of gfp tagged transgene by SOEing PCR
Three different protein isoforms are expressed from the W01A8.1 gene. The gene and the expressed proteins are denominated as W01A8.1 a, b and c (as accessed in Wormbase WS 246 on March 14, 2015). The gene coding for GFP is inserted before the STOP codon in the 7th exon (marked as W01A8.1a/c::gfp) or in the 6th exon of isoform b (marked as W01A8.1b::gfp). The transgene based on the first construct (covering the upper two isoforms a and c) may lead to the expression of both isoforms a or c fused to GFP dependent on the cellular context and is likely to lead also to overexpression of untagged isoform b from the extra-chromosomal array. The genomic map was designed using SnapGene software (from GSL Biotech; available at snapgene.com).
Generation of targeted deletions in W01A8.1 gene and selection with extra-chromosomal array
Panel A shows the genomic region of W01A8.1 gene being targeted by CRISPR/Cas9 sgRNAs at two marked positions +. After selection, the mutant CK123 (bottom) was generated and the genomic segment between primers #8134 and #8135 was PCR amplified and the resulting amplicon was sequenced from both directions using nested sequencing primers #8136 and #8137. It is clear from the sequencing alignment that a significant portion of the gene was disrupted while a small sequence, between the two sgRNA sites, was preserved. Panel B represents the extra-chromosomal array used for selection with the CRISPR/Cas9 based deletion shown in Panel A. The plasmid is carrying a synthetic version of W01A8.1a fused to gfp and was used as a potential balancer if loss of W01A8.1 would be lethal. The plasmid was injected together with mCherry selection markers and CRISPR/Cas9 sgRNA plasmids.The sequence alignment and graphics were designed using SnapGene software.
Analysis of number of progeny after W01A8.1 gene inhibition by RNAi
The graph shows the effect of RNAi mediated knockdown of W01A8.1 gene on the amount of progeny compared to control over a 24 hour period. The N2 animals were treated by RNAi directed against W01A8.1 for two generations and the amount of progeny was determined during a 24 hour period per one parent animal (18 parent animals were scored in both categories). (n = 1278 and n = 1813, respectively), P<0.05. The SD is indicated.
Analysis of the number of progeny laid by mutants with disrupted W01A8.1 and confirmed loss of the extrachromosomal array (CK123, KV001) and control N2 animals
The values show mild statistically significant difference in number of progeny laid by mutant worms CK123 compared to wild type N2 animals during the day 3 (Two Tailed T Test, p = 0.04962). Bars indicate SD.
Additional Information
Competing Interests
The authors declare they have no competing interests.
Author Contributions
Ahmed A. Chughtai conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper, prepared figures and/or tables, reviewed drafts of the paper.
Filip Kaššák conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper, prepared figures and/or tables, reviewed drafts of the paper.
Markéta Kostrouchová conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper, prepared figures and/or tables, reviewed drafts of the paper.
Jan Philipp Novotný conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper, reviewed drafts of the paper.
Michael W. Krause conceived and designed the experiments, analyzed the data, wrote the paper, reviewed drafts of the paper.
Vladimír Saudek conceived and designed the experiments, analyzed the data, wrote the paper, prepared figures and/or tables, reviewed drafts of the paper.
Zdenek Kostrouch conceived and designed the experiments, performed the experiments, analyzed the data, contributed reagents/materials/analysis tools, wrote the paper, prepared figures and/or tables, reviewed drafts of the paper, contributed with personal funds.
Marta Kostrouchová conceived and designed the experiments, performed the experiments, analyzed the data, contributed reagents/materials/analysis tools, wrote the paper, prepared figures and/or tables, reviewed drafts of the paper, contributed with personal funds.
Human Ethics
The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):
Human PLIN2 and PLIN3 were cloned from a collection of anonymous unmarked samples (PLIN2), and from human peripheral lymphocytes (PLIN3) donated by a volunteer with a written consent in compliance with the legislation of the Czech Republic and European Union (Act No 372/2011 of 11. 11. 2011 on Health Care Services, Coll., Paragraph 81, section 1a and section 4a, which is in accordance with the declaration of Helsinki and was approved by the Ethical Committee of the First Faculty of Medicine, Charles University in Prague).
Funding
This work was supported by the European Regional Development Fund “BIOCEV — Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec” (CZ.1.05/1.1.00/02.0109); the grant PRVOUK-P27/LF1/1 from Charles University in Prague; the grant SVV 260023 from Charles University in Prague. MWK is supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, USA (http://www2.niddk.nih.gov). MediCentrum Praha supported the work reported in this publication. ZK and MK contributed with personal funds to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.